TY - JOUR
T1 - Predictive validity of the adult tobacco dependence index
T2 - Findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study
AU - Strong, David R.
AU - Leas, Eric
AU - Noble, Madison
AU - White, Martha
AU - Frissell, Kevin C.
AU - Glasser, Allison
AU - Katz, Lauren
AU - Taylor, Kristie
AU - Compton, Wilson M.
AU - Conway, Kevin P.
AU - Lambert, Elizabeth
AU - Kimmel, Heather L.
AU - Silveira, Marushka L.
AU - Green, Victoria
AU - Hull, Lynn C.
AU - Cummings, K. Michael
AU - Hyland, Andrew
AU - Niaura, Ray
N1 - Funding Information:
This manuscript is supported with Federal funds from the National Institute on Drug Abuse , National Institutes of Health , and the Center for Tobacco Products, Food and Drug Administration, Department of Health and Human Services , under a contract to Westat (Contract No. HHSN271201100027C).
Funding Information:
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), partnered with the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products to conduct the Population Assessment of Tobacco and Health (PATH) Study under a contract with Westat. The PATH Study is an ongoing, nationally-representative, longitudinal cohort study of adults and youth in the US. The PATH Study uses audio computer-assisted self-interviews (ACASI) in English and Spanish to collect self-report information on tobacco-use patterns and associated health behaviors. W1 was conducted from September 12, 2013 to December 14, 2014; W2 was conducted from October 23, 2014 to October 30, 2015. The PATH Study recruitment employed stratified address-based, area-probability sampling design at W1 and oversampled adult tobacco users, young adults (18–24 years), and African-American adults. An in-person household screener was used at W1 to select youths and adults from households for participation in the longitudinal cohort.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Background and aims: Building on published work1 establishing concurrent validity of a self-report tobacco dependence (TD) index among users of different tobacco products in Wave 1 (W1) of the Population Assessment of Tobacco and Health (PATH) Study, the current study examines prospective relationships with tobacco use behaviors to establish predictive validity of the TD index. Hypotheses suggested high levels of W1 TD would be associated with persistent tobacco use at Wave 2 (W2). Participants: A U.S. nationally representative sample of 32,320 adult W1 and W2 interviews focused on 11,615 W1 adults who were current established tobacco users and completed the W2 interview. Findings: Higher TD scores and greater changes in TD scores were associated with greater quantity and frequency of tobacco use at the W2 interview for Cigarette Only (n = 7068), Smokeless (smokeless or snus pouches) Only (n = 772), Cigarette plus E-Cigarette (n = 592), and Multiple Products (n = 1866) users, although not significantly so for E-Cigarette Only (n = 367), Cigar Only (traditional, cigarillo, or filtered) (n = 584), or Hookah Only (n = 366) users. Higher TD was associated with decreased odds of successful quitting for Cigarette and Multiple Product users. Higher TD was associated with increased odds of a quit attempt for those in the Hookah and Multiple Products user groups and was not associated with quit attempts or deceased odds of quit success among exclusive E-Cigarette, Cigar, Smokeless and Cigarette plus E-Cigarette users. Conclusion: Support for the predictive validity of the PATH Study measures of adult TD will enable regulatory investigations of TD across several tobacco products.
AB - Background and aims: Building on published work1 establishing concurrent validity of a self-report tobacco dependence (TD) index among users of different tobacco products in Wave 1 (W1) of the Population Assessment of Tobacco and Health (PATH) Study, the current study examines prospective relationships with tobacco use behaviors to establish predictive validity of the TD index. Hypotheses suggested high levels of W1 TD would be associated with persistent tobacco use at Wave 2 (W2). Participants: A U.S. nationally representative sample of 32,320 adult W1 and W2 interviews focused on 11,615 W1 adults who were current established tobacco users and completed the W2 interview. Findings: Higher TD scores and greater changes in TD scores were associated with greater quantity and frequency of tobacco use at the W2 interview for Cigarette Only (n = 7068), Smokeless (smokeless or snus pouches) Only (n = 772), Cigarette plus E-Cigarette (n = 592), and Multiple Products (n = 1866) users, although not significantly so for E-Cigarette Only (n = 367), Cigar Only (traditional, cigarillo, or filtered) (n = 584), or Hookah Only (n = 366) users. Higher TD was associated with decreased odds of successful quitting for Cigarette and Multiple Product users. Higher TD was associated with increased odds of a quit attempt for those in the Hookah and Multiple Products user groups and was not associated with quit attempts or deceased odds of quit success among exclusive E-Cigarette, Cigar, Smokeless and Cigarette plus E-Cigarette users. Conclusion: Support for the predictive validity of the PATH Study measures of adult TD will enable regulatory investigations of TD across several tobacco products.
KW - Longitudinal national survey
KW - Nicotine dependence
KW - Validity
UR - http://www.scopus.com/inward/record.url?scp=85087349797&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087349797&partnerID=8YFLogxK
U2 - 10.1016/j.drugalcdep.2020.108134
DO - 10.1016/j.drugalcdep.2020.108134
M3 - Article
C2 - 32629146
AN - SCOPUS:85087349797
SN - 0376-8716
VL - 214
JO - Drug and alcohol dependence
JF - Drug and alcohol dependence
M1 - 108134
ER -